Abstract
Sotos syndrome is a genetic disorder resulting from heterozygous pathogenic variants or deletions in the nuclear receptor-binding SET domain protein 1 (NSD1) gene. It is characterized by prenatal and postnatal overgrowth, macrocephaly, distinctive craniofacial features, learning disability, and advanced bone maturation. In contrast, reverse Sotos syndrome, arises from duplications within the NSD1 gene, presenting with an opposite clinical phenotype, including microcephaly, developmental delay, short stature and delayed bone maturation. To date, the reverse clinical phenotype associated with the 5q35.2q35.3 microduplication encompassing the NSD1 gene has been reported in 43 cases. We present a novel case of a 4-years and 11-month-old boy with a 5q35.2q35.3 duplication involving the NSD1 gene. The patient, exhibited clinical features of microcephaly, short stature, low-normal weight, delayed bone age, developmental delay, attention deficit hyperactivity disorder, with normal routine biochemical tests, nutritional parameters, and insulin-like growth factor-1 levels. Chromosomal microarray analysis (CMA) identified a 714.1 kb duplication in the 5q35.2q35.3 region, including NSD1. This case reinforces the significance of NSD1 gene dosage alterations in manifesting a reverse Sotos clinical phenotype, typified by microcephaly and short stature. Furthermore, the utility of CMA as a robust diagnostic tool for detecting microrearrangements and guiding clinical evaluation is demonstrated.
Keywords: Sotos syndrome, reverse Sotos syndrome, NSD1, microduplication 5q35
Read the full text
5 sections · 2 figures · PDF
Create your free account to read the full text.
- Full text with figures and tables
- PDF and supplementary files
- Access on every Galenos journal
One Galenos account works on every Galenos journal site.
References
van der Lugt NM, Weerts MJA, Veenma DCM, Lincke CR, Gischler SJ, Alders M, van Ierland Y. 5q35 duplication syndrome: narrowing the critical region on the distal side and further evidence of intrafamilial variability and expression. Am J Med Genet A. 2023;191:835-841. Epub 2022 Dec 2
Quintero-Rivera F, Eno CC, Sutanto C, Jones KL, Nowaczyk MJM, Wong D, Earl D, Mirzaa G, Beck A, Martinez-Agosto JA. 5q35 duplication presents with psychiatric and undergrowth phenotypes mediated by NSD1 overexpression and mTOR signaling downregulation. Hum Genet. 2021;140:681-690. Epub 2021 Jan 3
Takkar A, Arora V, Saxena R, Kumar P, Verma IC. Reversal of clinical phenotype of Sotos syndrome due to microduplication of NSD1 gene. Indian J Pediatr. 2022;89:1137-1139. Epub 2022 Aug 4
Bernhardt IT, Gunn AJ, Carter PJ. Growth hormone treatment for short stature associated with duplication of the NSD1 Sotos syndrome gene. Endocrinol Diabetes Metab Case Rep. 2021;2021:20-0033.
Morishita M, di Luccio E. Cancers and the NSD family of histone lysine methyltransferases. Biochim Biophys Acta. 2011;1816:158-163. Epub 2011 Jun 6
Lucio-Eterovic AK, Singh MM, Gardner JE, Veerappan CS, Rice JC, Carpenter PB. Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function. Proc Natl Acad Sci U S A. 2010;107:16952-16957. Epub 2010 Sep 13
Tatton-Brown K, Cole TRP, Rahman N. Sotos syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds). GeneReviews®. University of Washington, Seattle; 2004.
Dikow N, Maas B, Gaspar H, Kreiss-Nachtsheim M, Engels H, Kuechler A, Garbes L, Netzer C, Neuhann TM, Koehler U, Casteels K, Devriendt K, Janssen JW, Jauch A, Hinderhofer K, Moog U. The phenotypic spectrum of duplication 5q35.2–q35.3 encompassing NSD1: is it really a reversed Sotos syndrome? Am J Med Genet A. 2013;161A:2158-2166.
Franco LM, de Ravel T, Graham BH, Frenkel SM, Van Driessche J, Stankiewicz P, Lupski JR, Vermeesch JR, Cheung SW. A syndrome of short stature, microcephaly and speech delay is associated with duplications reciprocal to the common Sotos syndrome deletion. Eur J Hum Genet. 2010;18:258-261. Epub 2009 Oct 21
Novara F, Stanzial F, Rossi E, Benedicenti F, Inzana F, Di Gregorio E, Brusco A, Graakjaer J, Fagerberg C, Belligni E, Silengo M, Zuffardi O, Ciccone R. Defining the phenotype associated with microduplication reciprocal to Sotos syndrome microdeletion. Am J Med Genet A. 2014;164A:2084-2090. Epub 2014 May 12
Rosenfeld JA, Kim KH, Angle B, Troxell R, Gorski JL, Westemeyer M, Frydman M, Senturias Y, Earl D, Torchia B, Schultz RA, Ellison JW, Tsuchiya K, Zimmerman S, Smolarek TA, Ballif BC, Shaffer LG. Further evidence of contrasting phenotypes caused by reciprocal deletions and duplications: duplication of NSD1 causes growth retardation and microcephaly. Mol Syndromol. 2013;3:247-254. Epub 2013 Jan 5
Chen CP, Lin SP, Lin CC, Chen YJ, Chern SR, Li YC, Hsieh LJ, Lee CC, Pan CW, Wang W. Molecular cytogenetic analysis of de novo dup(5)(q35.2q35.3) and review of the literature of pure partial trisomy 5q. Am J Med Genet A. 2006;140:1594-1600.
Zhang H, Lu X, Beasley J, Mulvihill JJ, Liu R, Li S, Lee JY. Reversed clinical phenotype due to a microduplication of Sotos syndrome region detected by array CGH: microcephaly, developmental delay and delayed bone age. Am J Med Genet A. 2011;155A:1374-1378. Epub 2011 May 12
Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, Pineda-Alvarez D, Aradhya S, Martin CL. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020;22:245-257. Epub 2019 Nov 6
Tatton-Brown K, Douglas J, Coleman K, Baujat G, Cole TR, Das S, Horn D, Hughes HE, Temple IK, Faravelli F, Waggoner D, Turkmen S, Cormier-Daire V, Irrthum A, Rahman N; Childhood Overgrowth Collaboration. Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet. 2005;77:193-204. Epub 2005 Jun 7
Jeong Y, Kim T, Kim S, Hong YK, Cho KS, Lee IS. Overexpression of histone methyltransferase NSD in Drosophila induces apoptotic cell death via the Jun-N-terminal kinase pathway. Biochem Biophys Res Commun. 2018;496:1134-1140. Epub 2018 Feb 2
